We believe that CAPE, being applied in the form of a topical cream or mouth rinsing solution, either alone or with 5-FU, can be a potentially effective treatment for patients with advanced oral cancer, targeting PI3K/Akt signaling, NF-κB, MMPs, and cell cycle regulatory proteins. This evidence concerns the gene PIK3CA and lip and oral cavity carcinoma.